Implementation of polygenic risk scores (PRS) may improve disease prevention and management
but poses several challenges: the construction of clinically valid assays, interpretation …

Evaluating the pathogenicity of a variant is challenging given the plethora of types of genetic
evidence that laboratories consider. Deciding how to weigh each type of evidence is difficult…

INTRODUCTION Large-scale genetic studies of integrated health care populations, with
phenotypic data captured natively in the documentation of clinical care, have the potential to …

Purpose: Hypertrophic cardiomyopathy (HCM) is caused primarily by pathogenic variants in
genes encoding sarcomere proteins. We report genetic testing results for HCM in 2,912 …

Genomic sequencing provides many opportunities in newborn clinical care, but the challenges
of interpreting and reporting newborn genomic sequencing (nGS) results need to be …

Importance Detection of disease-associated variants in theBRCA1andBRCA2(BRCA1/2)
genes allows for cancer prevention and early diagnosis in high-risk individuals. Objectives To …

Background Type 2 diabetes (T2D) is a worldwide scourge caused by both genetic and
environmental risk factors that disproportionately afflicts communities of color. Leveraging …

Despite rapid technical progress and demonstrable effectiveness for some types of diagnosis
and therapy, much remains to be learned about clinical genome and exome sequencing (…

There is growing interest in communicating clinically relevant DNA sequence findings to
research participants who join projects with a primary research goal other than the clinical …

Purpose Newborn screening (NBS) is performed to identify neonates at risk for actionable,
severe, early-onset disorders, many of which are genetic. The BabySeq Project randomized …